 | |
| Clinical data | |
|---|---|
| Other names | 2,5-Dimethoxy-3,4,6-trimethylamphetamine; Julia; 3,6-Dimethyl-DOM; 6-Methyl-Ganesha |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 7–9 hours [1] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C14H23NO2 |
| Molar mass | 237.343 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
DOTMA, also known as 2,5-dimethoxy-3,4,6-trimethylamphetamine or as Julia, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOM. [1] It is the 3,6-dimethyl derivative of DOM and the 6-methyl derivative of Ganesha. [1] The drug is said to be the first and only known active phenethylamine psychedelic with a fully substituted phenyl ring. [1] Its dose is approximately 70 mg orally and its duration is 7 to 9 hours. [1] DOTMA is less potent than DOM, which is active at doses of 3 to 10 mg, and has a shorter duration than DOM, which lasts 14 to 20 hours. [1] Similarly, DOTMA is less potent and shorter-acting than Ganesha, which has a dose of 20 to 32 mg and a duration of 18 to 24 hours. [1] DOTMA was described in the scientific literature by Daniel Trachsel in 2013. [1] The 6-methyl-DOM analogue of DOTMA and Ganesha, Juno, is relatively unknown but may be an active psychedelic as well. [1]
